Company Filing History:
Years Active: 2020
Title: Rhona Cox: Innovator in Pharmaceutical Research
Introduction
Rhona Cox is a prominent inventor based in Mölndal, Sweden. She has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds aimed at treating respiratory diseases.
Latest Patents
Rhona Cox holds a patent for "Inhibitors of phosphatidylinositol 3-kinase gamma." This patent discloses certain novel compounds, including pharmaceutically acceptable salts, that inhibit phosphatidylinositol 3-kinase gamma (PI3Kγ) activity. These compounds have potential utility in treating and preventing clinical conditions such as asthma and chronic obstructive pulmonary disease (COPD). The patent also covers their use in therapy, pharmaceutical compositions containing them, and processes for preparing such compounds. She has 1 patent to her name.
Career Highlights
Rhona Cox is associated with AstraZeneca AB, a leading global biopharmaceutical company. Her work focuses on innovative solutions to address significant health challenges, particularly in respiratory medicine.
Collaborations
Some of her notable coworkers include Mickael Mogemark and Nils Pemberton, who contribute to the collaborative efforts in research and development at AstraZeneca.
Conclusion
Rhona Cox's innovative work in pharmaceutical research exemplifies the impact of dedicated inventors in advancing medical science. Her contributions continue to pave the way for new treatments for respiratory diseases.